Gwen A. Melincoff - May 19, 2022 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Role: Director
Signature: Shirley R. Kuhlmann as Attorney-in-Fact for Gwen A. Melincoff
Stock symbol: COLL
Transactions as of: May 19, 2022
Transactions value $: $0
Form type: 4
Date filed: 5/23/2022, 05:42 PM
Previous filing: Jun 4, 2021
Next filing: Oct 14, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	COLL	Common Stock	Award	$0	+14K	+67%	$0.00	35K	May 19, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 19, 2023, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Content

Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 19, 2023, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.